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Genetic defects in the recombination acti-
vating genes, RAG1 and RAG2 are known
to impair V(D)J recombination in devel-
oping B and T-cells, thereby causing
T-B-severe combined immunodeficiency
(SCID) (1). Importantly, RAG defects with
residual recombination activity (hypomor-
phic mutations) give rise to the Omenn
syndrome, which is characterized by ery-
throderma, eosinophilia, hyper IgE, and the
presence of oligoclonal autoreactive T-cells
(2). In recent years, additional patients with
RAG mutations were identified that pre-
sented with atypical clinical features, rais-
ing important questions regarding diagno-
sis, and treatment strategies (3). Further-
more, the underlying mechanism explain-
ing how this clinical heterogeneity can be
caused by mutations in these RAG genes
remained unclear. Recently, Lee et al. deter-
mined the level of residual recombination
activity of mutant RAG proteins and found
that it correlated well with the clinical phe-
notype of the patients (4). However, this
was only part of the story because IJspeert
et al. showed that 22 patients with simi-
lar RAG mutations presented with different
clinical presentations (5) Thus, the vary-
ing degrees of immune dysregulation in
RAG-deficient patients cannot be predicted
solely based on the RAG gene defect.
The study of Rucci et al. in Frontiers in
Immunology provided new insight into the
role of thymic stroma in immune regu-
lation (6). Following earlier observations
of abnormalities in thymic stroma and
impaired expression of AIRE and tis-
sue specific antigens (TSA) in thymus
of Omenn syndrome patients (7, 8), the
authors studied two murine models of
leaky SCID: rag1S/S mice with hypomor-
phic S723C substitutions in the rag1 gene
and lig4R/R mice with R278H mutations in
the gene encoding DNA ligase IV. The
rag1S/S mice display severe combined
immunodeficiency with residual devel-
opment of oligoclonal and functionally
impaired T-cells, and some mice develop
features consistent with Omenn syndrome
(9). The lig4R/R mice have a leaky SCID
phenotype without features of Omenn
syndrome (10).
Both rag1S/S and lig4R/R mice showed
a significant reduction in thymus size and
cellularity due to decreased absolute num-
bers of CD4+CD8+ double positive (DP)
as well as of CD4 and CD8 single posi-
tive (SP) thymocytes. Thymic development
was arrested incompletely at DN3 stage,
consistent with a V(D)J recombination
defect. Newly generated SP thymocytes in
both models underwent maturation in the
medulla, but this intra-thymic maturation
was accelerated as evidenced by skewing
toward a more mature phenotype, prob-
ably accompanied by homeostatic prolifer-
ation in a lymphopenic microenvironment
(11). The rag1S/S and lig4R/R models dif-
fered in the diversity of the thymic TCR
repertoire: this was polyclonal in thymo-
cytes of lig4R/R mice, whereas rag1S/S mice
displayed a highly restricted TCR reper-
toire, similar to that of Omenn syndrome
patients.
To study the nature of this difference, the
authors subsequently focused on thymic
epithelial cells (TEC). Cortical (c)TECs
and medullary (m)TECs play a critical role
in thymic selection and central tolerance
(Figure 1A), and cross-talk with developing
thymocytes is crucial for TEC maturation
and for maintenance of thymic architecture
(12). The thymic demarcation between
the cortex and the medulla was preserved
lig4R/R mice, whereas it was completely
absent in rag1S/S mice. In rag1S/S mice, this
disrupted architecture also resulted in the
absence of AIRE-expressing mTECs. AIRE
regulates the expression of genes encoding
peripheral tissue-specific antigens (TSAs).
Presentation of TSA peptides by mTECs or
dendritic cells leads to tolerance via clonal
deletion of self-reactive thymocytes or by
facilitating differentiation into natural reg-
ulatory T (nTreg) cells. nTreg cells were
severely reduced in number, but still dis-
played a regulatory function. This is in
contrast to Omenn syndrome patients that
show disturbed nTreg function.
In summary, the authors showed
that the degree by which hypomorphic
mutations impair T-cell development is
associated with the defects in thymic
stroma architecture and AIRE and TSA
expression in mTECs. Especially, when
the differentiation block only allows dif-
ferentiation of a few thymocytes with a
restricted TCR gene repertoire, the thymus
defects lead to immune dysregulation. Both
mouse models showed similar reduction
in thymus size and cellularity. Still, rag1s/s
mice showed a restriction in their TCR
gene repertoire as compared with lig4R/R.
Thus, despite the differential impact of
these mutations on V(D)J recombination,
homeostatic processes in the thymus com-
pensated the lower production in rag1s/s
mice with additional proliferation. The
association of immune dysregulation with
TCR repertoire restriction has recently
been confirmed through next generation
sequencing of TCRβ gene rearrangements
in patients with hypomorphic SCID and
immune dysregulation (13). These patients
had mutations in RAG1/2, the common γ-
chain of the IL-2 receptor and ζ-associated
protein kinase 70 (ZAP70), which all affect
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FIGURE 1 | PrecursorT-cell differentiation in human thymus.
(A) Thymocyte differentiation and their migration through the anatomic
niches. The earliest double negative (DN) thymocytes enter the thymus
at the cortico-medullary junction and migrate to the sub-capsular zone.
In humans, 3 DN subsets can be identified: DN1, CD34+CD38−CD1a−;
DN2, CD34+CD38+CD1a−; DN3, CD34+CD38+CD1a+ (14).
Subsequently, these upregulate CD4 and become immature single
positive (ISP), followed by CD3+CD4+CD8+ double positive (DP) and
finally into CD3+CD4+ or CD3+CD8+ single positive (SP) cells while
passing through the cortex and the medulla. (B) Human T-cell
differentiation stages including V(D)J recombination bars (14) and
genetic defects underlying PID that result in impaired precursor
differentiation. The indicated developmental blocks largely rely on data
from targeted mutation studies in the mouse.
T-cell differentiation prior to the SP stage
(Figure 1B).
Thus, the article by Rucci et al. has
begun to provide a rationale for the
various degrees of immune dysregulation
in patients with Omenn syndrome or
atypical SCID. Central tolerance in the thy-
mus appears to play a key role and seems to
be influenced by the combination of the
generated TCR repertoire and the “TSA
repertoire” as expressed by mTECs and
DC. The clinical phenotype of hypomor-
phic mutations will depend on the level
of residual activity of the affected protein,
the number, the immunophenotype, and
clonality of the generated thymocytes, and
via these on the thymic architecture and
the number and “diversity” of mTECs. The
prospects of high-throughput sequencing
of TCR gene rearrangements will likely
provide further insights into the diversity
in immune dysregulation in SCID.
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